Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (101-110 of 244) with videos related to

Pageof 25
Sort By:
Journal for Immunotherapy of Cancer|October 25, 2023
Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumorsSophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever, et al.
Plos One|March 11, 2014
Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemiaHanna Janke, Friederike Pastore, Daniela Schumacher, et al.
Frontiers in Immunology|December 7, 2020
Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T CellsSaskia Schmitt, Siret Tahk, Alina Lohner, et al.
Blood|October 3, 2018
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemiaMonika Herrmann, Christina Krupka, Katrin Deiser, et al.
Cell|October 17, 2017
The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3Moritz M Gaidt, Thomas S Ebert, Dhruv Chauhan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2016
Features of Human CD3+CD20+ T CellsElisabeth Schuh, Kerstin Berer, Matthias Mulazzani, et al.
Clinical and Experimental Medicine|July 13, 2024
Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemiaRamya Nair, Alejandro Salinas-Illarena, Monika Sponheimer, et al.
Cancer Cell|October 6, 2023
Cooperative CAR targeting to selectively eliminate AML and minimize escapeSascha Haubner, Jorge Mansilla-Soto, Sarah Nataraj, et al.
Journal of Hematology & Oncology|September 28, 2021
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cellsSiret Tahk, Binje Vick, Björn Hiller, et al.
Pageof 25

Showing results (101-110 of 244) with videos related to

Sort By:
Pageof 25
Journal for Immunotherapy of Cancer|October 25, 2023
Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumorsSophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever, et al.
Plos One|March 11, 2014
Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemiaHanna Janke, Friederike Pastore, Daniela Schumacher, et al.
Frontiers in Immunology|December 7, 2020
Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T CellsSaskia Schmitt, Siret Tahk, Alina Lohner, et al.
Blood|October 3, 2018
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemiaMonika Herrmann, Christina Krupka, Katrin Deiser, et al.
Cell|October 17, 2017
The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3Moritz M Gaidt, Thomas S Ebert, Dhruv Chauhan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2016
Features of Human CD3+CD20+ T CellsElisabeth Schuh, Kerstin Berer, Matthias Mulazzani, et al.
Clinical and Experimental Medicine|July 13, 2024
Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemiaRamya Nair, Alejandro Salinas-Illarena, Monika Sponheimer, et al.
Cancer Cell|October 6, 2023
Cooperative CAR targeting to selectively eliminate AML and minimize escapeSascha Haubner, Jorge Mansilla-Soto, Sarah Nataraj, et al.
Journal of Hematology & Oncology|September 28, 2021
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cellsSiret Tahk, Binje Vick, Björn Hiller, et al.
Pageof 25